,Dr. Kelly's Wife sold CYDY stock when Dr. Kelly had access to unblinded CoV CD12 data and was not public information (Form 144 filed).
From CYDY;s SEC filing:
"the Company and certain of its executives have received subpoenas in connection with an investigation being conducted by the United States Department of Justice. The subpoenas seek testimony and/or records concerning, among other matters, leronlimab, the Company’s public statements regarding the use of leronlimab as a potential treatment for COVID-19 and related communications with the FDA, investors, and others, and trading in the securities of CytoDyn."